Hypopharyngeal large cell neuroendocrine carcinoma

4Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Neuroendocrine carcinoma (NEC) of the head and neck is rare. We report a case of a 56-year-old man with a 6-week history of dysphagia, a neck mass and weight loss. He was diagnosed with a hypopharyngeal large cell NEC (LCNEC) with metastases to multiple sites. He received two cycles of cisplatin and etoposide. Subsequent restaging scan revealed progressive disease. The patient declined further chemotherapy and died shortly after. This is the third case of LCNEC of hypopharynx reported in the English literature and the first to progress on platinum-based chemotherapy. Although LCNEC of the head and neck is still classified as an atypical carcinoid, there is increasing evidence it is a distinct clinicohistopathological entity that carries an especially poor prognosis. Currently, there is a paucity of data to guide treatment of this rare malignancy.

Cite

CITATION STYLE

APA

Lee, W. I., Ameratunga, M., Du Plessis, J., & Gan, H. (2015). Hypopharyngeal large cell neuroendocrine carcinoma. BMJ Case Reports, 2015. https://doi.org/10.1136/bcr-2015-211908

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free